You are here

In the News

The US Food and Drug Administration (FDA) announced Monday that Dr. Amy Abernethy will replace Rachel Sherman as Principal Deputy commissioner of Food and Drugs – the highest position at the agency...Read more

Friends of Cancer Research Applauds this Appointment and Thanks Dr. Rachel Sherman for Her Incredible Service
December 17, 2018 - Washington, DC - Today, the U.S. Food and Drug Administration (FDA...Read more

One of the leading voices in using health data to advance targeted treatments known as precision medicine has been tapped for the second-highest post at the FDA.
Amy Abernethy, chief medical...Read more

Executive Summary
O’Brien assumes role from his late colleague and friend Dan Best as HHS closes out administrative items in the blueprint.
The Trump Administration appears to be ramping up towards...Read more

Federal regulators put two experimental drugs targeting autism’s core symptoms on a fast track for testing and approval this year, but they’re still a long way from pharmacy shelves.
Balovaptan,...Read more

Executive Summary
Amid concerns Office of New Drugs reorganization will result in sponsors receiving conflicting advice, new director offers several items already contemplated to prevent such...Read more

The National Cancer Institute (NCI) updated its clinical trial criteria to allow patients with specific health concerns to participate in NCI-funded clinical trials, as well as provide opportunities...Read more

The National Cancer Institute (NCI) has revised its clinical trial protocol template to expand eligibility criteria for cancer clinical trials. The updated criteria will allow patients with certain...Read more